Previous studies had demonstrated that overexpression of ATAD2 at the transcriptional level via miR-372 regulation promotes tumor malignancy and consequently results in poor outcome in liver adenocarcinoma patients [11]. The gene discussed is ATAD2; the disease is neoplasm.